IVLAV
IPSC icon

Index Venture Life Associates VI’s Century Therapeutics IPSC Stock Holding History

Index Venture Life Associates VI’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-188,251
Closed -$190K – 2
2024
Q4 		$190K Buy
+188,251
New +$256K 0.11% 2

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Index Venture Life Associates VI's IPSC Position: Q1 2025 in Review

Index Venture Life Associates VI sold out of Century Therapeutics (IPSC) in Q1 2025, closing a stake of 188,251 shares — an estimated $190K sold.

Index Venture Life Associates VI first reported a position in IPSC in Q4 2024 and held it in 1 quarter. The position peaked at $190K in Q4 2024. 70 funds tracked by Wall St. Rank hold IPSC as of Q1 2025.

  • Index Venture Life Associates VI reported no remaining Century Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Index Venture Life Associates VI sold 188,251 Century Therapeutics shares in Q1 2025, an estimated $190K.
  • Index Venture Life Associates VI first reported a position in Century Therapeutics in Q4 2024 and held it in 1 quarter.
  • Index Venture Life Associates VI's Century Therapeutics position peaked at $190K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2025.

Based on Index Venture Life Associates VI's 13F filing for Q1 2025, filed 15 May 2025.